Screener
Altimmune ALT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Altimmune’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 334,676 | 278,192 |
| Property and equipment, net | 208 | 312 |
| Other assets | 746 | 1,425 |
| Total assets | $335,630 | $279,929 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,530 | $2,717 |
| Accrued expenses and other current liabilities | 9,793 | 12,280 |
Item 1. Financial Statements
FAQ
- What is Altimmune's total assets?
- Altimmune (ALT) reported total assets of $335.63M in Q1 2026.
- How has Altimmune's total assets changed year-over-year?
- Altimmune's total assets increased by 113.4% year-over-year, from $157.26M to $335.63M.
- What is the long-term trend for Altimmune's total assets?
- Over 5 years (2020 to 2025), Altimmune's total assets has grown at a 2.7% compound annual growth rate (CAGR), from $245.12M to $279.93M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Altimmune's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude